News & Updates
Filter by Specialty:
TNF inhibition beyond 24 weeks: How safe in pregnant mums?
02 Nov 2022
byElvira Manzano
Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.
TNF inhibition beyond 24 weeks: How safe in pregnant mums?
02 Nov 2022Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
01 Nov 2022
byRoshini Claire Anthony
Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
01 Nov 2022Oral GnRH antagonists effective in endometriosis-related pain, dysmenorrhea
01 Nov 2022
Oral gonadotropin-releasing hormone (GnRH) antagonists help relieve pain in women with endometriosis or dysmenorrhea, according to the results of a meta-analysis.